Abiopharma

🔍 Budman Gleb (Director)

Company: Backblaze, Inc. (BLZE)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 128,205 shares of Class A Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,251,051.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Class A common stock for each RSU. The RSUs are subject to a service-based vesting requirement, which will vest on a quarterly basis over approximately 3 years with the first 1/12th tranche vesting on May 14, 2026, provided that the Reporting Person remains in continuous service through each such vesting date.